CYLD and breast carcinoma: It has been reported that both disease-free survival and breast cancer-specific survival were significantly reduced in breast cancer patients with low CYLD expression [19], and overall survival was significantly reduced in hepatocellular carcinoma patients with low CYLD expression [21], suggesting that loss of CYLD expression may be associated with poor prognosis in various cancers.